2026 Robert J. Schneider: Biology and Biochemistry Researcher – H-Index, Publications & Awards

D-Index & Metrics

Discipline name	D-Index	World Ranking	Current World Ranking	National Ranking	Current National Ranking	Publications	Citations
Biology and Biochemistry	93	2104	1907	1143	1018	396	31910
Medicine	97	9307	8734	4802	4440	436	33713

Discipline name

D-Index

World Ranking

Current World Ranking

National Ranking

Current National Ranking

Publications

Citations

Biology and Biochemistry

2104

1907

1143

1018

396

31910

Medicine

9307

8734

4802

4440

436

33713

Biology and Biochemistry

D-Index

Citations

31910

World Ranking

2104

National Ranking

1143

Medicine

D-Index

Citations

33713

World Ranking

9307

National Ranking

4802

Overview

Robert J. Schneider is affiliated with New York University in the United States. Their research spans multiple areas primarily in medicine and biochemistry, genetics, and molecular biology. The subfields of study in which they have published include molecular biology, oncology, immunology, surgery, and cancer research.

The scientist's main topics of work cover RNA modifications and cancer, RNA and protein synthesis mechanisms, RNA research and splicing, immune cell function and interaction, PI3K/AKT/mTOR signaling in cancer, HER2/EGFR in cancer research, and breast cancer treatment studies.

Recent notable publications by Robert J. Schneider include:

Neurons Release Serine to Support mRNA Translation in Pancreatic Cancer, 2020, Cell
m7G tRNA modification reveals new secrets in the translational regulation of cancer development, 2021, Molecular Cell
Macrophage-Derived 25-Hydroxycholesterol Promotes Vascular Inflammation, Atherogenesis, and Lesion Remodeling, 2022, Circulation
Inflammatory breast cancer defined: proposed common diagnostic criteria to guide treatment and research, 2022, Breast Cancer Research and Treatment
A DAP5/eIF3d alternate mRNA translation mechanism promotes differentiation and immune suppression by human regulatory T cells, 2021, Nature Communications

Frequent co-authors in their body of work include Olga Katsara, Blake Kooima, Samir Atiya, Dominick J. DiMaio, and Amreen Masthan.

Robert J. Schneider has published regularly in venues such as Graduate Medical Education Research Journal, Cancer Research, Frontiers in Oncology, Molecular Cancer Research, and arXiv (Cornell University).

Best Publications

DNA exonuclease Trex1 regulates radiotherapy-induced tumour immunogenicity.

Claire Vanpouille-Box;Amandine Alard;Amandine Alard;Molykutty J. Aryankalayil;Yasmeen Sarfraz

1684
Citations
Translational control in cancer.

Deborah Silvera;Silvia C. Formenti;Robert J. Schneider

1079
Citations
Methylation of histone H3 Lys 4 in coding regions of active genes.

Bradley E. Bernstein;Emily L. Humphrey;Rachel L. Erlich;Robert Schneider

990
Citations
Radiation-induced CXCL16 release by breast cancer cells attracts effector T cells.

Satoko Matsumura;Baomei Wang;Noriko Kawashima;Steve Braunstein

771
Citations
Survey of Animal Neoplasms in Alameda and Contra Costa Counties, California. II. Cancer Morbidity in Dogs and Cats From Alameda County

C. R. Dorn;D. O. N. Taylor;R. Schneider;H. H. Hibbard

665
Citations
The Enigmatic X Gene of Hepatitis B Virus

Michael J. Bouchard;Robert J. Schneider

649
Citations
HEPATITIS B VIRUS HBX PROTEIN ACTIVATES RAS-GTP COMPLEX FORMATION AND ESTABLISHES A RAS, RAF, MAP KINASE SIGNALING CASCADE

Jacqueline Benn;Robert J. Schneider

609
Citations
Control of mRNA Decay by Heat Shock-Ubiquitin-Proteasome Pathway

Gaurav Laroia;Rafael Cuesta;Gary Brewer;Robert J. Schneider

583
Citations
Adenovirus VAI RNA is required for efficient translation of viral mRNAs at late times after infection.

Bayar Thimmappaya;Cary Weinberger;Robert J. Schneider;Thomas Shenk

541
Citations
Alveolar regeneration through a Krt8+ transitional stem cell state that persists in human lung fibrosis

Maximilian Strunz;Lukas M. Simon;Meshal Ansari;Jaymin J. Kathiriya

497
Citations
Calcium signaling by HBx protein in hepatitis B virus DNA replication.

Michael J. Bouchard;Li-Hua Wang;Robert J. Schneider

487
Citations
Adenovirus VAI RNA antagonizes the antiviral action of interferon by preventing activation of the interferon-induced eIF-2α kinase

Jan Kitajewski;Robert J. Schneider;Brian Safer;Susan M. Munemitsu

477
Citations
The hepatitis B virus HBx protein is a dual specificity cytoplasmic activator of Ras and nuclear activator of transcription factors.

M. Doria;N. Klein;R. Lucito;R. J. Schneider

446
Citations
Hepatitis B virus HBx protein sensitizes cells to apoptotic killing by tumor necrosis factor alpha.

Fei Su;Robert J. Schneider

416
Citations
Hepatitis B virus HBx protein deregulates cell cycle checkpoint controls.

Jacqueline Benn;Robert J. Schneider

412
Citations
Hepatitis B virus HBx protein induces transcription factor AP-1 by activation of extracellular signal-regulated and c-Jun N-terminal mitogen-activated protein kinases.

Jacqueline Benn;Fei Su;Margherita Doria;Robert J. Schneider

401
Citations
A Hypoxia-Controlled Cap-Dependent to Cap-Independent Translation Switch in Breast Cancer

Steve Braunstein;Ksenia Karpisheva;Carolina Pola;Judith Goldberg

371
Citations
Unsafe SETs: histone lysine methyltransferases and cancer

Robert Schneider;Andrew J. Bannister;Tony Kouzarides

367
Citations
Hepatitis B virus HBx protein activates transcription factor NF-kappaB by acting on multiple cytoplasmic inhibitors of rel-related proteins.

F Su;R J Schneider

335
Citations
Translational Control in Cancer

Nathaniel Robichaud;Nahum Sonenberg;Davide Ruggero;Robert J. Schneider

225
Citations